[Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
The monitoring of the use of anabolic hormones in patients with progressive Duchenne's muscular dystrophy was shown to be possible with the help of the clinical analysis of the patients' motor possibilities, electroneuromyographic examination and determination of the time-course of the urinary excretion of catecholamines and DOPA.
D002395:Catecholamines / Q000652:urine*; D002648:Child; D004295:Dihydroxyphenylalanine / Q000652:urine*; D004568:Electrodiagnosis; D004576:Electromyography; D006801:Humans; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000188:drug therapy* / Q000652:urine; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D009431:Neural Conduction
D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D009277:Nandrolone; D000077603:Nandrolone Decanoate
Vliianie retabolila na dinamiku urinarnoĭ ékskretsii katekholaminov, DOFA i élektroneĭromiograficheskikh pokazateleĭ u bol'nykh s miodistrofieĭ Diushenna.